18 September 2020PatentsMuireann Bolger

USPTO announces COVID-19 deferred-fee patent application programme

The United States Patent and Trademark Office (USPTO) has unveiled a deferred-fee provisional patent application pilot programme for inventions that combat COVID-19.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Patents

‘Suspect’ China filings driven by govt subsidies and targets, says USPTO

14 January 2021 The exponential growth in trademarks and patents filed in the US from China may be partially fuelled by subsidies by the Chinese government, according to a new report released by the US Patent and Trademark Office.

Patents

USPTO issues 11 millionth patent

12 May 2021 The US Patent and Trademark Office has issued US patent number 11 million to 4C Medical Technologies for its prosthetic heart valve invention.

Patents

USPTO increases ‘fast-track’ examinations limit to 15,000

27 September 2021 The US Patent and Trademark Office has announced applicants can file for more prioritised examinations following an increase to the annual limit.

INTA announces 2025 president, updates TM guidelines, launches new 'Think Tank'

L'Oréal sued over virtual makeup try-on simulator

Kathi Vidal to leave USPTO ahead of incoming Trump administration

Huawei moves to strike out US trade secrets and fraud allegations

Q&A: EagleView counsel maps out route to IPR victory

Herbert Smith Freehills and Kramer Levin in $2bn merger talks

WIPO in Saudi Arabia to finalise design law treaty

Civil RICO: A trade secrets super weapon

USPTO announces COVID-19 deferred-fee patent application programme

More on this story

Editor's picks

Editor's picks

More articles